Status:
COMPLETED
Construction of Clinical Diagnostic Model for Pulmonary Hypertension
Lead Sponsor:
RenJi Hospital
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
Brief Summary
Primary objective: To establish a non-invasive diagnostic model for pulmonary hypertension based on laboratory indicators and echocardiographic parameters. Secondary objectives: To investigate the co...
Detailed Description
Data collection: Collect vital signs (age, sex, etc.), clinical laboratory tests (complete blood count, biochemistry, BNP, D-dimer, and related derived parameters), and echocardiographic data from bo...
Eligibility Criteria
Inclusion
- Patients diagnosed with any subtype of pulmonary hypertension (PH) confirmed by right heart catheterization (RHC) between 2020 and 2025.
- No gender restrictions; age \>18 years.
- Availability of complete RHC records, transthoracic echocardiography (TTE), and laboratory test results (echocardiography and lab tests must be performed within one month before or after RHC).
Exclusion
- Pulmonary veno-occlusive disease (PVOD)
- Active or history of malignancy (or Malignant tumors if referring to current cases)
- Hematologic disorders
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT06979011
Start Date
January 1 2025
End Date
April 30 2025
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Shanghai, Shanghai Municipality, China